Search company, investor...

Founded Year



Series C | Dead

Total Raised


Last Raised


About QuadraSpec

Quadraspec is changing the face of diagnostic medicine. Quadraspec's patented SDI label-free detection technology aims to permit the rapid analysis of up to 100 unique tests on up to 1,000 unique patients per hour. Quadraspec's , multiplex-capable diagnostics platform aims to allow high throughput, label-free, highly sensitive bioassays, and diagnostics.

Headquarters Location

3000 Kent Avenue

West Lafayette, Indiana, 47906,

United States




Latest QuadraSpec News

Quadraspec Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 30, 2016

Quadraspec, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 20:58 EST 29 Nov 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Quadraspec, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Quadraspec, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Quadraspec, Inc. since January 2007. Key Findings Provides intelligence on Quadraspec, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Quadraspec, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Quadraspec, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Quadraspec, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

QuadraSpec Frequently Asked Questions (FAQ)

  • When was QuadraSpec founded?

    QuadraSpec was founded in 2004.

  • Where is QuadraSpec's headquarters?

    QuadraSpec's headquarters is located at 3000 Kent Avenue, West Lafayette.

  • What is QuadraSpec's latest funding round?

    QuadraSpec's latest funding round is Series C.

  • How much did QuadraSpec raise?

    QuadraSpec raised a total of $10.3M.

  • Who are the investors of QuadraSpec?

    Investors of QuadraSpec include Spring Mill Venture Partners, EDF Ventures, 1st Source Capital Corporation, CHV Capital and Village Ventures.

  • Who are QuadraSpec's competitors?

    Competitors of QuadraSpec include VIDA Diagnostics, Ikonisys, Binx Health, Decipher Biosciences, Foundation Medicine and 7 more.


Compare QuadraSpec to Competitors

NIR Diagnostics

NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.


Knoesis seeks to develop bio-analytical hardware and reagents enabling cost-effective clinical diagnostics. The vision of the company is to allow everyone affordable access to rapid and specific diagnostic healthcare knowledge. Knoesis' first application is an immunosensor for the detection of latent tuberculosis infection.

Hx Diagnostics

Hx Diagnostics offers rapid diagnostics for seasonal and emerging infectious diseases.


CyberGene is a company that operates in the MedTech field. The company's main offerings include diagnostics for prenatal conditions, pregnancy loss, and male infertility. These services primarily cater to the healthcare industry. It was founded in 1995 and is based in Sweden.


Tympany is developing automated, hearing, diagnostic technology. Tympany aims to improve early detection of hearing loss, increase access to diagnostics, and facilitate the ease and convenience of personalized treatment. The company is located in The Woodlands, Texas, with regional offices throughout the U.S

Optasia Medical Logo
Optasia Medical

Optasia Medical aims to build medical imaging-based Computer Assisted Detection (CAD) solutions to help physicians make better decisions. With Optasia Medical's tools, medical images can be evaluated more rapidly, more accurately and more reproducibly. The Optasia platform aims to enable robust model-based vision solutions to automated medical image interpretation problems. With Optasia, new applications can be developed rapidly for seamless integration into the clinical workflow.nOptasia Medical is applying the Optasia platform to problems in musculoskeletal disease. Specifically, for the analysis of X-ray images in the detection and monitoring of osteoporosis, osteoarthritis and rheumatoid arthritis and the planning and assessment of orthopedic surgery


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.